Related Experiment Video
Updated: Aug 9, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Systems analysis of adverse drug events. ADE Prevention Study Group
L L Leape1, D W Bates, D J Cullen
1Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA.
JAMA
|July 5, 1995
Summary
System failures in drug knowledge dissemination and patient information access cause most adverse drug events (ADEs). Improving these systems can reduce medication errors and improve patient safety.
Area of Science:
- Healthcare quality and safety
- Medication error analysis
- Health systems research
Background:
- Adverse drug events (ADEs) and potential ADEs represent a significant patient safety concern.
- Understanding the root causes of these events is crucial for developing effective prevention strategies.
Purpose of the Study:
- To identify and evaluate the systems failures underlying errors that lead to adverse drug events (ADEs) and potential ADEs.
- To pinpoint common systemic weaknesses in hospital drug use processes.
Main Methods:
- A prospective cohort study involving systems analysis of events across 11 medical and surgical units in two tertiary care hospitals over six months.
- Errors were detected through interviews and classified by proximal cause and underlying systems failure by multidisciplinary teams.
Main Results:
- 334 errors causing 264 preventable ADEs and potential ADEs were identified.
- Sixteen major systems failures were found, with drug knowledge dissemination (29%) and patient information availability (18%) being the most common.
- Seven systems failures accounted for 78% of errors, highlighting the potential impact of improved information systems.
Conclusions:
- Hospital staff actively participated in identifying systems failures related to drug use errors.
- Deficiencies in systems for disseminating drug knowledge and accessing patient information were primary contributors to errors.
- Enhancing drug and patient data systems is essential for reducing medication errors and improving patient safety.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...